论文部分内容阅读
AIM To investigate the therapeutic potential of two recombinant proteins,Survivin and luteinizing hormone-releasing hormone(LHRH)fusion protein[LHRH(6leu)-LTB]for immunotherapy of breast cancer.METHODS Murine 4T-1 breast cancer model was used to evaluate